MedTrace Logo

Meditation Awareness Training for the Treatment of Fibromyalgia Syndrome

NCT02800720 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 148

Last updated 2016-06-15

No results posted yet for this study

Summary

A Randomised Controlled Trial to evaluate the effectiveness of a Second-Generation Mindfulness-Based Intervention known as Meditation Awareness Training (MAT) for treating fibromyalgia syndrome.

Conditions

  • Fibromyalgia Syndrome

Interventions

BEHAVIORAL

Meditation Awareness Training

8 Week Meditation Intervention

BEHAVIORAL

Cognitive Behavioral Therapy for Groups

8 week intervention based on Cognitive Behavioral Theory

Sponsors & Collaborators

  • Nottingham Trent University

    lead OTHER

Principal Investigators

  • William Van Gordon · Nottingham Trent University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2014-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02800720 on ClinicalTrials.gov